| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3312114 | Journal de Chirurgie Viscérale | 2012 | 8 Pages |
Abstract
Neoadjuvant radiochemotherapy for elderly patients (age > 70 years) with esophageal adenocarcinoma did not seem to increase postoperative morbidity or mortality, nor was there any difference in quality of life, nor any effect on survival, no matter what the age of the patient.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
A. Camerlo, X.-B. D'Journo, M. Ouattara, D. Trousse, C. Doddoli, P.-A. Thomas,